Group 1: Telix Pharmaceuticals Limited (NASDAQ:TLX) - Class action lawsuits have been initiated on behalf of stockholders of Telix Pharmaceuticals Limited, with a lead plaintiff deadline set for January 9, 2026 [1] - The lawsuit alleges that during the class period from February 21, 2025, to August 28, 2025, defendants made false and misleading statements regarding the progress of Telix's prostate cancer therapeutic candidates and the quality of its supply chain [7] - Investors are claiming damages due to the misleading information that affected their investment decisions when the true details were revealed [7] Group 2: Firefly Aerospace Inc. (NASDAQ:FLY) - A class action lawsuit has also been filed for stockholders of Firefly Aerospace Inc., with a lead plaintiff deadline of January 12, 2026 [1] - The complaint states that the Offering Documents related to Firefly's IPO on August 7, 2025, were negligently prepared, overstating demand for its Spacecraft Solutions and the operational readiness of its Alpha rocket program [7] - Following disappointing financial results reported on September 22, 2025, Firefly's stock price dropped by $7.58 per share (15.31%), and further declined by $7.66 per share (20.73%) after a significant operational failure was disclosed on September 29, 2025, leading to ongoing trading below the IPO price of $45.00 per share [7]
Bragar Eagel & Squire, P.C. Reminds Investors of Telix Pharmaceuticals and Firefly Aerospace to Contact the Firm About their Rights Before Lead Plaintiff Deadlines